191 related articles for article (PubMed ID: 34383877)
1. Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer.
Mohan RR; Balne PK; Muayad MS; Tripathi R; Sinha NR; Gupta S; An JA; Sinha PR; Hesemann NP
Transl Vis Sci Technol; 2021 Aug; 10(10):5. PubMed ID: 34383877
[TBL] [Abstract][Full Text] [Related]
2. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
[TBL] [Abstract][Full Text] [Related]
3. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.
Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414
[TBL] [Abstract][Full Text] [Related]
4. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.
Mohan RR; Tovey JC; Sharma A; Schultz GS; Cowden JW; Tandon A
PLoS One; 2011; 6(10):e26432. PubMed ID: 22039486
[TBL] [Abstract][Full Text] [Related]
5. The functional role of decorin in corneal neovascularization in vivo.
Balne PK; Gupta S; Zhang J; Bristow D; Faubion M; Heil SD; Sinha PR; Green SL; Iozzo RV; Mohan RR
Exp Eye Res; 2021 Jun; 207():108610. PubMed ID: 33940009
[TBL] [Abstract][Full Text] [Related]
6. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.
Mohan RR; Sinha S; Tandon A; Gupta R; Tovey JC; Sharma A
PLoS One; 2011 Apr; 6(4):e18771. PubMed ID: 21533273
[TBL] [Abstract][Full Text] [Related]
7. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Safety and Tolerability of BMP7 and HGF Gene Overexpression in Rabbit Cornea.
Gupta S; Sinha NR; Martin LM; Keele LM; Sinha PR; Rodier JT; Landreneau JR; Hesemann NP; Mohan RR
Transl Vis Sci Technol; 2021 Aug; 10(10):6. PubMed ID: 34383876
[TBL] [Abstract][Full Text] [Related]
9. Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.
Gupta S; Fink MK; Ghosh A; Tripathi R; Sinha PR; Sharma A; Hesemann NP; Chaurasia SS; Giuliano EA; Mohan RR
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1045-1057. PubMed ID: 29490341
[TBL] [Abstract][Full Text] [Related]
10. A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.
Tripathi R; Balne PK; Sinha NR; Martin LM; Kamil S; Landreneau JR; Gupta S; Rodier JT; Sinha PR; Hesemann NP; Hofmann AC; Fink MK; Chaurasia SS; Mohan RR
Transl Vis Sci Technol; 2020 Nov; 9(12):6. PubMed ID: 33200047
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent in situ structural and cellular aberrations in rabbit cornea in vivo after mustard gas exposure.
Sinha NR; Tripathi R; Balne PK; Green SL; Sinha PR; Bunyak F; Giuliano EA; Chaurasia SS; Mohan RR
Exp Eye Res; 2022 Nov; 224():109247. PubMed ID: 36113569
[TBL] [Abstract][Full Text] [Related]
12. Vector delivery technique affects gene transfer in the cornea in vivo.
Mohan RR; Sharma A; Cebulko TC; Tandon A
Mol Vis; 2010 Nov; 16():2494-501. PubMed ID: 21139995
[TBL] [Abstract][Full Text] [Related]
13. BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.
Tandon A; Sharma A; Rodier JT; Klibanov AM; Rieger FG; Mohan RR
PLoS One; 2013; 8(6):e66434. PubMed ID: 23799103
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the AlgerBrush II rotating burr as a tool for inducing ocular surface failure in the New Zealand White rabbit.
Li FJ; Nili E; Lau C; Richardson NA; Walshe J; Barnett NL; Cronin BG; Hirst LW; Schwab IR; Chirila TV; Harkin DG
Exp Eye Res; 2016 Jun; 147():1-11. PubMed ID: 27085211
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery in the equine cornea: a novel therapeutic strategy.
Buss DG; Giuliano E; Sharma A; Mohan RR
Vet Ophthalmol; 2010 Sep; 13(5):301-6. PubMed ID: 20840107
[TBL] [Abstract][Full Text] [Related]
16. Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.
Gupta S; Rodier JT; Sharma A; Giuliano EA; Sinha PR; Hesemann NP; Ghosh A; Mohan RR
PLoS One; 2017; 12(3):e0172928. PubMed ID: 28339457
[TBL] [Abstract][Full Text] [Related]
17. [A preliminary study on the safety of berberine solution in rabbit eyes with topical application].
Zhang Y; Bai F; Tao H
Zhonghua Yan Ke Za Zhi; 2020 Feb; 56(2):131-137. PubMed ID: 32074824
[No Abstract] [Full Text] [Related]
18. Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.
Daull P; Raymond E; Feraille L; Garrigue JS
J Ocul Pharmacol Ther; 2018 Dec; 34(10):670-676. PubMed ID: 30312113
[No Abstract] [Full Text] [Related]
19. Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation.
Donnelly KS; Giuliano EA; Sharma A; Tandon A; Rodier JT; Mohan RR
Vet Ophthalmol; 2014 May; 17(3):162-9. PubMed ID: 23718145
[TBL] [Abstract][Full Text] [Related]
20. A rabbit model for evaluating ocular damage from acrolein toxicity in vivo.
Gupta S; Fink MK; Martin LM; Sinha PR; Rodier JT; Sinha NR; Hesemann NP; Chaurasia SS; Mohan RR
Ann N Y Acad Sci; 2020 Nov; 1480(1):233-245. PubMed ID: 33067838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
